114
Participants
Start Date
June 30, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
peginesatide
Participants received peginesatide by intravenous injection once every 4 weeks at the starting dose of 0.04 milligram per kilogram (mg/kg); the dose was adjusted throughout the study to maintain a hemoglobin target range of 11.0-12.0 grams per deciliter (g/dL).
peginesatide
Participants received peginesatide by intravenous injection once every 4 weeks at the starting dose of 0.08 mg/kg; the dose was adjusted throughout the study to maintain a hemoglobin target range of 11.0-12.0 g/dL.
Epoetin Alfa
Participants received Epoetin alfa by intravenous injection three times a week at the starting dose of 50 Units/kg. The dose was adjusted throughout the study to maintain a hemoglobin target range of 11.0-12.0 g/dL.
Research Facility, Irkutsk
Research Facility, Krasnodar
Research Facility, Krasnoyarsk
Research Facility, Moscow
Research Facility, Nizhny Novgorod
Research Facility, Omsk
Research Facility, Petrozavodsk
Research Facility, Saint Petersburg
Research Facility, Saratov
Research Facility, Tver'
Research Facility, Volzhsk